Dr. Redondo is Professor of Pediatrics at Baylor College of Medicine and a Pediatric Endocrinologist at Texas Children’s Hospital in Houston, Texas, United States.

Dr. Redondo’s research overall goal is to dissect the heterogeneity of diabetes to bring closer the goal of precision medicine. One of her NIH NIDDK funded projects aims to incorporate genetic risk scores in the predictive model for type 1 diabetes and use genetics to improve the selection of candidates for prevention trials in the Type 1 Diabetes TrialNet Study. Her Diabetes Study in Children of Diverse Ethnicity and Race (DISCOVER), also funded by NIDDK, seeks to use genetics for timely and accurate diagnosis of diabetes type in children of diverse ancestry with the ultimate goal to improve clinical outcomes. She is also part of the NIDDK-funded Rare and Atypical Diabetes Network (RADIANT), and the American Diabetes Association Precision Medicine in Diabetes Initiative. She was part of the Precision Medicine in Diabetes Initiative funded by the American Diabetes Association and the European Association for the Study of Diabetes, and is now part of the NIDDK-sponsored Heterogeneity of Diabetes project.